Cyclosporine inhibits specific sIgA production against cholera toxin but not trinitrophenyl-lipopolysaccharide in small bowel transplantation.
Xia
W
W
Department of Surgery, Brigham and Women's Hospital, Boston, MA 02115.
Kirkman
R L
RL
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D002772:Cholera Toxin / Q000276:immunology*; D016572:Cyclosporine / Q000494:pharmacology* / Q000627:therapeutic use; D004731:Endotoxins / Q000276:immunology*; D007071:Immunoglobulin A, Secretory / Q000096:biosynthesis*; D007421:Intestine, Small / Q000637:transplantation*; D008070:Lipopolysaccharides / Q000276:immunology*; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D014184:Transplantation, Homologous / Q000276:immunology; D014185:Transplantation, Isogeneic / Q000276:immunology
D004731:Endotoxins; D007071:Immunoglobulin A, Secretory; D008070:Lipopolysaccharides; C048761:trinitrophenyl-lipopolysaccharide; D016572:Cyclosporine; D002772:Cholera Toxin